Clinical Trial

A Dose-Escalation Study of RO7875913 in Healthy Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the safety, pharmacokinetics, and pharmacodynamics of RO7875913 in healthy participants.
Protocol Amendment History 1 change
critical Recruitment opened 2026-03-31
Trial Details
NCT Number NCT07342114
Lead Sponsor Genentech, Inc.
Conditions Healthy Volunteers
Enrollment 40 participants
Start Date 2026-03-11
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-20